Population Pharmacokinetics of Dolutegravir in HIV-Infected Pediatric Subjects

被引：0
|
作者：
Singh, Rajendra P. [1 ]
Edwards, Alena Yin [2 ]
Ruel, Theodore [3 ]
Wiznia, Andrew [4 ]
Acosta, Edward [5 ]
Hazra, Rohan [6 ]
Buchanan, Ann M. [7 ]
机构：
[1] GlaxoSmithKline, CPMS, Philadelphia, PA USA
[2] ICON Plc Ireland, Dublin, Ireland
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] NICHD, NIH, Bethesda, MD USA
[7] ViiV Healthcare, Res Triangle Pk, NC USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-64
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pediatric Patients
    Bouazza, Naim
    Urien, Saik
    Hirt, Deborah
    Frange, Pierre
    Rey, Elisabeth
    Benaboud, Sihem
    Foissac, Frantz
    Blanche, Stephane
    Treluyer, Jean-Marc
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 58 (03) : 283 - 288
  • [32] Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects
    Cimoch, PJ
    Lavelle, J
    Pollard, R
    Griffy, KG
    Wong, R
    Tarnowski, TL
    Casserella, S
    Jung, D
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (03): : 227 - 234
  • [33] Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects
    Parks, David A.
    Jennings, Harold C.
    Taylor, Christopher W.
    Acosta, Edward P.
    AIDS, 2007, 21 (10) : 1373 - 1375
  • [34] Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals
    Dickinson, Laura
    Boffito, Marta
    Back, David J.
    Khoo, Saye H.
    Pozniak, Anton L.
    Mugyenyi, Peter
    Merry, Concepta
    Autar, Reshma Saskia
    Burger, David M.
    Aarons, Leon J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1344 - 1355
  • [35] Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected and healthy individuals
    Dickinson, Laura
    Aarons, Leon
    Back, David
    Khoo, Saye
    Else, Laura
    Waters, Laura
    Pozniak, Anton
    Boffito, Marta
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 304 - 305
  • [36] Population pharmacokinetics of ainuovirine and exposure-response analysis in the HIV-infected individuals
    Su Bin
    Sun Jin
    Zhang Yihang
    Jiang Taiyi
    Xia Wei
    Zhang Tong
    Sun Lijun
    Wu Hao
    Qin Hong
    Yun Xinming
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 : 21 - 21
  • [37] Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach
    Dailly, E.
    Raffi, F.
    Perre, P.
    Martin, J.
    Deslandes, G.
    Jolliet, P.
    HIV MEDICINE, 2009, 10 (09) : 586 - 589
  • [38] Population pharmacokinetics (PopPK) guided dose selection of TAF in HIV-infected children
    Gupta, Sneha V.
    Majeed, Sophia R.
    Liu, Ya-Pei
    Graham, Hiba
    Pikora, Cheryl
    Mathias, Anita
    Sharma, Shringi
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S124 - S125
  • [39] Pediatric vaccines in HIV-infected children
    Agosti, Jan M.
    CURRENT OPINION IN HIV AND AIDS, 2007, 2 (05) : 385 - 390
  • [40] Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
    Mulligan, Nikki
    Schalkwijk, Stein
    Best, Brookie M.
    Colbers, Angela
    Wang, Jiajia
    Capparelli, Edmund V.
    Molto, Jose
    Stek, Alice M.
    Taylor, Graham
    Smith, Elizabeth
    Tenorio, Carmen Hidalgo
    Chakhtoura, Nahida
    van Kasteren, Marjo
    Fletcher, Courtney V.
    Mirochnick, Mark
    Burger, David
    FRONTIERS IN PHARMACOLOGY, 2016, 7
12345